Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cells.
Pancreatic and colorectal carcinomas frequently express oncogenic/mutant K-Ras that contributes to both tumorigenesis and clinically observed resistance to radiation treatment. We have previously shown that farnesyltransferase inhibitors (FTI) radiosensitize many pancreatic and colorectal cancer cel...
Main Authors: | Cengel, K, Voong, K, Chandrasekaran, S, Maggiorella, L, Brunner, T, Stanbridge, E, Kao, G, Mckenna, W, Bernhard, E |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2007
|
Similar Items
-
Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-Ras.
by: Brunner, T, et al.
Published: (2005) -
Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines.
by: Bernhard, E, et al.
Published: (2000) -
The Role of Wild-Type RAS in Oncogenic RAS Transformation
by: Erin Sheffels, et al.
Published: (2021-04-01) -
Radiation sensitization by inhibition of activated Ras.
by: Brunner, T, et al.
Published: (2004) -
Ras inhibitors and radiation therapy.
by: Jones, H, et al.
Published: (2001)